Treatment Failure and Clinical Stability in Severe Community-Acquired Pneumonia

被引：0
|
作者：
Mendez, Raul [1 ,2 ,3 ,4 ]
Gonzalez-Jimenez, Paula [1 ,2 ,3 ]
Mengot, Noe [1 ,2 ]
Menendez, Rosario [1 ,2 ,3 ,4 ,5 ]
机构：
[1] La Fe Univ & Polytech Hosp, Pneumol Dept, Valencia, Spain
[2] Hlth Res Inst La Fe IISLAFE, Resp Infect, Valencia, Spain
[3] Univ Valencia, Dept Med, Valencia, Spain
[4] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Resp, Madrid, Spain
[5] Hosp Univ & Politecn La Fe, Serv Neumol, Avda Fernando Abril Martorell 106, Valencia 46026, Spain
来源：
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 45卷 / 02期
关键词：
CAP; inflammatory-immune response; microbiologic treatment; RESPIRATORY-DISTRESS-SYNDROME; INFECTIOUS-DISEASES-SOCIETY; LENGTH-OF-STAY; HOSPITALIZED-PATIENTS; ANTIBIOTIC-TREATMENT; THORACIC-SOCIETY; RISK-FACTORS; EARLY SWITCH; TIME; OUTCOMES;
D O I：
10.1055/s-0043-1778139
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
Treatment failure and clinical stability are important outcomes in community-acquired pneumonia (CAP). It is essential to know the causes and risk factors for treatment failure and delay in reaching clinical stability in CAP. The study of both as well as the associated underlying mechanisms and host response are key to improving outcomes in pneumonia.
引用
收藏
页码：225 / 236
页数：12
相关论文
共 50 条
  • [31] CLINICAL EFFECT OF ERTAPENEM IN THE TREATMENT OF SEVERE COMMUNITY-ACQUIRED PNEUMONIA IN ELDERLY PATIENTS
    Ni, J.
    Sun, R.
    Hu, G-P
    RESPIROLOGY, 2011, 16 : 57 - 57
  • [32] Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia
    Endimiani, A
    Brigante, G
    Bettaccini, AA
    Luzzaro, F
    Grossi, P
    Toniolo, AQ
    BMC INFECTIOUS DISEASES, 2005, 5 (1)
  • [33] Early and Late Treatment Failure in Community-Acquired Pneumonia
    Garcia-Vidal, Carolina
    Carratala, Jordi
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 30 (02) : 154 - 160
  • [34] Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia
    Andrea Endimiani
    Gioconda Brigante
    Alessia A Bettaccini
    Francesco Luzzaro
    Paolo Grossi
    Antonio Q Toniolo
    BMC Infectious Diseases, 5
  • [35] Community-acquired pneumonia: causes of treatment failure in patients enrolled in clinical trials
    Genne, D
    Kaiser, L
    Kinge, TN
    Lew, D
    CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (09) : 949 - 954
  • [36] Early noninvasive ventilation treatment for respiratory failure due to severe community-acquired pneumonia
    Nicolini, Antonello
    Pisani, Lara
    Cilloniz, Catia
    Ferraioli, Gianluca
    MINERVA PNEUMOLOGICA, 2019, 58 (01) : 27 - 35
  • [37] Predictors of treatment failure and clinical stability in patients with community acquired pneumonia
    Morley, Deirdre
    Torres, Antoni
    Cilloniz, Catia
    Martin-Loeches, Ignacio
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (22)
  • [38] Therapy for severe community-acquired pneumonia
    Berk, SL
    CLINICAL INFECTIOUS DISEASES, 1997, 25 (01) : 168 - 168
  • [39] Defining severe community-acquired pneumonia
    Neuhaus, T
    Ewig, S
    MEDICAL CLINICS OF NORTH AMERICA, 2001, 85 (06) : 1413 - +
  • [40] Hydrocortisone in severe community-acquired pneumonia
    Kevin Guo
    Krishan Yadav
    Hans Rosenberg
    Canadian Journal of Emergency Medicine, 2023, 25 : 656 - 658
12345